Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
u6vA3THTjC6APsgx
